Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Ad Delay Pending Collection Of Post-Marketing Data Endorsed By ASHP

Executive Summary

Direct-to-consumer advertising should be delayed for new drug products pending analysis of post-marketing surveillance data, the American Society of Health-System Pharmacists suggested at an FDA public hearing Nov. 1-2

You may also be interested in...



Is A Picture Worth A Thousand Words? – FDA Evaluation Of DTC Images Urged

FDA should consider the impact of images on consumer behavior as part of its evaluation of direct-to-consumer advertisements, the National Research Center for Women & Families suggested

Is A Picture Worth A Thousand Words? – FDA Evaluation Of DTC Images Urged

FDA should consider the impact of images on consumer behavior as part of its evaluation of direct-to-consumer advertisements, the National Research Center for Women & Families suggested

FDA Needs Health Communications Advisory Cmte. For DTC Policy, Pitts Says

An advisory committee on healthcare communications should be created to inform FDA's direct-to-consumer advertising policies, former FDA Associate Commissioner For External Relations Peter Pitts suggested at an FDA public hearing on DTC advertising Nov. 1-2

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS046516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel